DACOGEN
Live / Registered — Registered and renewed (as of 06 Jun 2016)
What this means for you
Registered since 09 Jan 2007. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 09 Jan 2017).
Record
- Serial number
- 78216191
- Registration number
- 3197209
- Mark type
- Word mark
- Filed
- 18 Feb 2003
- Published for opposition
- 23 Sept 2003
- Registered
- 09 Jan 2007
- Next maintenance due
- 09 Jan 2017
- Attorney of record
- Harold Milstein
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical compositions for treating cancer and immune disorders
Owner
- ASTEX PHARMACEUTICALS, INC., Pleasanton, CA, US
- Supergen, Inc., Dublin, CA, US
- Supergen, Inc., Dublin, CA, US
- Supergen, Inc., Dublin, CA, US
Prosecution history
- 09 Jan 2026 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 15 Apr 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 15 Apr 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 15 Apr 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 06 Jun 2016 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 06 Jun 2016 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 06 Jun 2016 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 06 Jun 2016 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 18 Mar 2016 — TEAS SECTION 8 & 9 RECEIVED
- 09 Jan 2016 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 30 Mar 2015 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 30 Mar 2015 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 07 Jan 2013 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 07 Jan 2013 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 07 Jan 2013 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL